Search

Your search keyword '"Ziol M."' showing total 401 results

Search Constraints

Start Over You searched for: Author "Ziol M." Remove constraint Author: "Ziol M."
401 results on '"Ziol M."'

Search Results

1. Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular Carcinoma

2. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

3. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

5. Reply to Rokx et al

6. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD : an individual patient data meta-analysis

8. Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus‐co‐infected patients (ANRS CO13‐HEPAVIH)

9. Post‐HCV cure self‐reported changes in physical activity, eating behaviours, and fatigue in people living with HIV (ANRS CO13 HEPAVIH)

10. Facteurs histologiques associés à une complication hépatique au cours de la sarcoïdose hépatique : analyse descriptive anatomoclinique à partir d’une cohorte multicentrique de 92 patients

13. Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH)

14. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: An individual patient data meta-analysis

15. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: An individual patient data meta-analysis

18. Serum keratin 19 (CYFRA21-1) links ductular reaction with portal hypertension and outcome of various advanced liver diseases

19. Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH)

25. PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases

30. Determination of candidate metabolite biomarkers associated with recurrence of HCV-related hepatocellular carcinoma

33. Virologic control increased overall survival after radiofrequency ablation of hepatocellular carcinoma developed on hepatitis related cirrhosis

34. Macrotrabecular-massive hepatocellular carcinoma: a distinctive histological subtype with clinical relevance

35. Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference

36. Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH)

39. Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease

42. FRI-141 - Macrotrabecular-massive hepatocellular carcinoma: a distinctive histological subtype with clinical relevance

46. P0359 : ESM-1 is a marker of microvascular invasion, satellite nodules, and adverse clinical outcome in patients with hepatocellular carcinoma treated by surgical resection

47. P0384 : Assessment of treatment response by sequential serum metabolomic profiling after percutaneous radiofrequency ablation of hepatocellular carcinoma

48. O054 TM6SF2-T and PNPLA3-G genetic variants co-modulate the risk of hepatocellular carcinoma in caucasian patients with alcoholic cirrhosis. Inter-cohort validation in 1068 patients

Catalog

Books, media, physical & digital resources